Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Photobiomodulation therapy as a high potential treatment modality for COVID-19

In recent years, photobiomodulation (PBM) has shown promising results in reducing acute pulmonary inflammation.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors describe COVID-19 as causing severe cases in which immune impairment leads to cytokine release and acute respiratory distress syndrome. They note that photobiomodulation has shown promising results in reducing acute pulmonary inflammation and hypothesize that it could be an effective treatment for ARDS in COVID-19 patients. This appears to be a hypothesis-driven proposal rather than a report of clinical results.

Who or what was studied
COVID-19 patients, particularly those with severe disease and acute respiratory distress syndrome
Limits stated in the abstract
The abstract presents a hypothesis without reporting any patient outcomes or experimental data.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Inflammation. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies